Document Detail


Augmented plasma protein C activity after coronary thrombolysis with urokinase in patients with acute myocardial infarction.
MedLine Citation:
PMID:  1387346     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Coronary thrombolysis reduces morbidity and mortality in patients with acute myocardial infarction, however, the exact effects of thrombolytic agents on the status of intrinsic hemostases are not fully understood. In the present study, we examined serial changes in plasma thrombin and protein C activities of 6 patients with acute myocardial infarction treated with urokinase. Fibrinolysis occurred immediately after urokinase injection with an increase in the plasma thrombin-antithrombin III complex, suggesting a subsequent procoagulant state due to thrombin generation. Correspondent increases in plasma protein C activity were observed, however, protein S levels did not change at all. Our findings suggest that urokinase administration for coronary thrombolysis not only causes fibrinolysis, but also induces thrombin activity, which may be antagonized by augmented intrinsic protein C activity.
Authors:
S Goto; S Handa; Y Kawai; K Watanabe; S Abe; E Takahashi; S Hori; Y Ikeda
Related Documents :
1623876 - Fatal haemostatic complications due to thrombolytic therapy in patients falsely diagnos...
6647196 - Reduction of left ventricular damage with intracoronary streptokinase in acute myocardi...
8426066 - Thrombolysis in acute myocardial infarction: a hospital emergency room experience.
2529036 - Staged thrombolysis and percutaneous transluminal coronary angioplasty for unstable and...
23258316 - Global and regional longitudinal strain assessed by two-dimensional speckle tracking ec...
3341226 - Inducible atrial flutter after the mustard repair of complete transposition of the grea...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Cardiology     Volume:  80     ISSN:  0008-6312     ISO Abbreviation:  Cardiology     Publication Date:  1992  
Date Detail:
Created Date:  1992-10-01     Completed Date:  1992-10-01     Revised Date:  2008-11-21    
Medline Journal Info:
Nlm Unique ID:  1266406     Medline TA:  Cardiology     Country:  SWITZERLAND    
Other Details:
Languages:  eng     Pagination:  252-6     Citation Subset:  IM    
Affiliation:
Cardiopulmonary Division, Keio University School of Medicine, Tokyo, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Antithrombin III / metabolism
Blood Proteins / metabolism
Glycoproteins / metabolism
Humans
Male
Middle Aged
Myocardial Infarction / blood,  drug therapy*
Peptide Hydrolases / metabolism
Protein C / metabolism*
Protein S
Thrombin / metabolism
Thrombolytic Therapy*
Urokinase-Type Plasminogen Activator / therapeutic use*
Chemical
Reg. No./Substance:
0/Blood Proteins; 0/Glycoproteins; 0/Protein C; 0/Protein S; 0/antithrombin III-protease complex; 9000-94-6/Antithrombin III; EC 3.4.-/Peptide Hydrolases; EC 3.4.21.5/Thrombin; EC 3.4.21.73/Urokinase-Type Plasminogen Activator

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Role of arterial hypertension in left ventricle hypertrophy in hemodialysis patients: an echocardiog...
Next Document:  MHC-unrestricted recognition of bacteria-infected target cells by human CD8+ cytotoxic T lymphocytes...